Funded Tech Companies
AnaCardio
Wondering who backed AnaCardio? 3B Ventures, Flerie Invest and Karolinska invested in this innovative biopharmaceutical company.
Company Overview
Company Name
AnaCardio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
A Working Lab Innomedicum, Nanna Svartz väg 4
Solna, 171 65
Sweden
Solna, 171 65
Sweden
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
AnaCardio AB is a privately held Swedish, clinical stage biopharmaceutical company developing novel drugs to treat heart failure. AnaCardio was founded based on ground-breaking research from Karolinska Institutet showing improved contractility of the heart muscle through a unique and differentiated mechanism. Its lead program AC01 is planned to enter phase 2 clinical development in heart failure patients in 2022.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/9/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Lars Lund
Chief Executive Officer
Patrik Strömberg
Company Investors
- 3B Ventures
- Flerie Invest
- Karolinska
- Private Investors (Ann-Helene Ljungström)
- Private Investors (Fredrik Ljungstrom)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs